EVIDENCE OF T-CELL ACTIVATION AND POTENTIAL CYTOKINE ACTION IN HUMAN ENDOMETRIUM

被引:60
作者
TABIBZADEH, S [1 ]
机构
[1] CUNY MT SINAI SCH MED, NEW YORK, NY 10029 USA
关键词
D O I
10.1210/jcem-71-3-645
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Antigenic epitopes have been described whose expression characterizes early or late stages of activation of Tcells. In this study the expression of early activation antigen, interleukin-2 receptor was compared with the expression of late activation antigens, HLA-DR, HLA-DP, and HLA-DQ molecules of the major histocompatibility complex II, and very late activation antigen, VLA-1 of the integrin superfamily of molecules in 43 human endometria. These molecules were localized by their reactivity with monoclonal antibodies in an avidinbiotin-complex procedure. Interleukin-2 receptor was not expressed in human endometria; however, endometrial T-cells within lymphoid aggregates, some scattered in endometrial stroma and a few within epithelium, expressed HLA-DR, HLADP, HLA-DQ, and VLA-1. In addition, expression of the receptor of interferon-ᵞ, a product of activated T-cells, was observed on endometrial epithelium. Evidence for activation of T-cells and expression of interferon-ᵞ receptor in human endometrial epithelium suggests that endometrium may be an active site for cytokine action. © 1990 by The Endocrine Society.
引用
收藏
页码:645 / 649
页数:5
相关论文
共 30 条
[1]  
BONO MR, 1982, NATURE, V209, P836
[3]   TRANSIENT EXPRESSION OF INTERLEUKIN-2 RECEPTORS - CONSEQUENCES FOR T-CELL GROWTH [J].
CANTRELL, DA ;
SMITH, KA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 158 (06) :1895-1911
[4]   REGULATION OF HLA-DR, DP, AND DQ EXPRESSION IN ACTIVATED T-CELLS [J].
GANSBACHER, B ;
ZIER, KS .
CELLULAR IMMUNOLOGY, 1988, 117 (01) :22-34
[5]   INVESTIGATION OF INVIVO ACTIVATED T-CELLS IN MULTIPLE-SCLEROSIS AND INFLAMMATORY CENTRAL NERVOUS-SYSTEM DISEASES [J].
HAFLER, DA ;
HEMLER, ME ;
CHRISTENSON, L ;
WILLIAMS, JM ;
SHAPIRO, HM ;
STROM, TB ;
STROMINGER, JL ;
WEINER, HL .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1985, 37 (02) :163-171
[6]  
HELMER ME, 1986, J CLIN INVEST, V78, P696
[7]  
HELMER ME, 1984, J IMMUNOL, V132, P3011
[8]  
HELMER ME, 1985, EUR J IMMUNOL, V15, P502
[9]  
HELMER ME, 1985, J BIOL CHEM, V28, P15246
[10]   USE OF AVIDIN-BIOTIN-PEROXIDASE COMPLEX (ABC) IN IMMUNOPEROXIDASE TECHNIQUES - A COMPARISON BETWEEN ABC AND UNLABELED ANTIBODY (PAP) PROCEDURES [J].
HSU, SM ;
RAINE, L ;
FANGER, H .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1981, 29 (04) :577-580